✦ LIBER ✦

Genetic Prodrug Activation Therapy for Pancreatic Cancer

✍ Scribed by A. S. RIGG; N. R. LEMOINE

Book ID: 111395782
Publisher: John Wiley and Sons
Year: 1999
Tongue: English
Weight: 173 KB
Volume: 880
Category: Article
ISSN: 0890-6564
DOI: 10.1111/j.1749-6632.1999.tb09535.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Genetic prodrug activation therapy

✍ LA Martin; R Vile; NR Lemoine; K Sikora; HS Pandha 📂 Article 📅 1997 🏛 The Lancet 🌐 English ⚖ 99 KB

Developments in genetic prodrug activati

Developments in genetic prodrug activation therapy

📂 Article 📅 1998 🏛 Adis International Limited (now part of Wolters Kl ⚖ 148 KB

Cell death associated with genetic prodr

Cell death associated with genetic prodrug activation therapy of colorectal cancer

✍ Stephen Todryk; Alan Melcher; Graham Bottley; Michael Gough; Richard Vile 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 213 KB

Prodrug activation enzymes in cancer gen

Prodrug activation enzymes in cancer gene therapy

✍ Manish Aghi; Fred Hochberg; Xandra O. Breakefield 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB 👁 2 views

Among the broad array of genes that have been evaluated for tumor therapy, those encoding prodrug activation enzymes are especially appealing as they directly complement ongoing clinical chemotherapeutic regimes. These enzymes can activate prodrugs that have low inherent toxicity using both bacteria

Troxacitabine Prodrugs for Pancreatic Ca

Troxacitabine Prodrugs for Pancreatic Cancer

✍ Adema, A. D.; Radi, M.; Daft, J.; Narayanasamy, J.; Hoebe, E. K.; Alexander, L. 📂 Article 📅 2007 🏛 Taylor and Francis Group 🌐 English ⚖ 158 KB

The role of adenoviral vectors in geneti

The role of adenoviral vectors in genetic prodrug activation therapy in prostate cancer

✍ Eaton, J D; Clarke, I A; Pandha, H; Dalgleish, A G; Kirby, R S 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 34 KB